Ownership and insider activity for DarioHealth Corp. (DRIO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management.
Price
| Price | $6.78 |
| Market Cap | $50M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-23 | Matheis Dennis | P-Purchase | 14,430 | $100K |
| 2024-08-12 | Matheis Dennis | C-Conversion | 965 | $18K |
| 2024-08-12 | Matheis Dennis | C-Conversion | 50 | $50K |
| 2026-04-10 | PALUMBO JOHN R | |||
| 2025-09-11 | Nelson Steven Charles | A-Award | 30,000 | |
| 2025-09-11 | STERN ADAM K | A-Award | 20,000 | |
| 2025-09-11 | Leisure Lawrence B. | A-Award | 20,000 | |
| 2025-09-11 | Shaked Yoav | A-Award | 20,000 | |
| 2025-09-11 | Raphael Erez | A-Award | 60,000 | |
| 2025-09-11 | Franco-Yehuda Chen | A-Award | 5,000 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.1M | $3.7M | $11.0M | $20.6M | $28.6M | $36.0M | $49.4M | $36.8M | $27.8M | $26.2M |
| Short-term Investments | $225000 | $258000 | 0 | 0 | 0 | 0 | 0 | 0 | $697000 | 0 |
| Receivables | $290000 | $435000 | $234000 | $712000 | $1.7M | $1.8M | $6.4M | $3.6M | $5.4M | $2.7M |
| Inventory | $888000 | $1.2M | $1.4M | $1.4M | $2.3M | $6.2M | $8.0M | $5.1M | $4.8M | $4.3M |
| Total Current Assets | $2.9M | $6.0M | $13.3M | $22.9M | $34.1M | $45.6M | $65.5M | $47.3M | $40.5M | $34.8M |
| Property, Plant & Equipment | $901000 | $869000 | $733000 | $1.4M | $1.1M | $989000 | $2.0M | $1.9M | $1.8M | $1.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | $41.6M | $41.6M | $41.6M | $57.4M | $57.4M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | $12.5M | $9.9M | $5.4M | $18.8M | $15.9M |
| Total Assets | $3.9M | $7.0M | $14.1M | $24.6M | $35.4M | $100.8M | $119.2M | $96.4M | $118.9M | $110.1M |
| Accounts Payable | $1.8M | $1.9M | $2.6M | $1.7M | $2.5M | $5.1M | $2.3M | $1.1M | $3.0M | $2.9M |
| Short-term Debt | 0 | 0 | 0 | $317000 | 0 | $266000 | $8.8M | $4.0M | $5.5M | $430000 |
| Total Current Liabilities | $2.9M | $3.0M | $5.2M | $5.2M | $7.0M | $14.4M | $19.4M | $12.5M | $16.6M | $9.3M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | $18.1M | $24.6M | $23.5M | $30.7M |
| Total Liabilities | $10.4M | $3.0M | $5.2M | $5.7M | $7.3M | $15.2M | $39.2M | $38.2M | $46.9M | $42.2M |
| Retained Earnings | -$55.0M | -$71.0M | -$89.3M | -$110.1M | -$143.2M | -$222.0M | -$285.9M | -$349.4M | -$390.3M | -$452.1M |
| Total Equity | -$6.5M | $3.9M | $8.9M | $18.9M | $28.2M | $85.5M | $80.0M | $58.1M | $72.0M | $67.9M |
| Total Debt | 0 | 0 | 0 | $772000 | $532000 | $287000 | $28.0M | $29.5M | $30.2M | $31.7M |
| Net Debt | -$1.3M | -$4.0M | -$11.0M | -$19.8M | -$28.1M | -$35.7M | -$21.3M | -$7.3M | $1.7M | $5.5M |
| Working Capital | $11000 | $3.0M | $8.1M | $17.7M | $27.1M | $31.2M | $46.2M | $34.8M | $23.9M | $25.5M |
Financial Health
| Debt / Equity | 0.59 |
| Current Ratio | 2.31 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 1.67 |
Profitability
| Return on Equity | 104.15% |
| Return on Invested Capital | -78.42% |
| Return on Assets | 70.17% |
| Gross Margin | 56.09% |
| Operating Margin | -328.83% |
| Net Margin | 322.77% |
Related companies: ABSI · AVNS · FLGT · INNV · MYGN · NNNN · OFIX
Explore sector: Healthcare · Medical - Specialties
More sections of DRIO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks